Polyphor Gets New Funding to Develop Inhaled Antibiotic Murepavadin for Respiratory Diseases Like CF
News
Polyphor and the European Innovative Medicines Initiative (IMI) will fund up to 10 million euros (around $11.6 million U.S.) to support and advance the development of an inhaled formulation of Polyphor’s investigational ... Read more